Home/Filings/4/0001267602-20-000019
4//SEC Filing

Kaba Samer 4

Accession 0001267602-20-000019

CIK 0001267602other

Filed

Jan 13, 7:00 PM ET

Accepted

Jan 14, 4:32 PM ET

Size

5.3 KB

Accession

0001267602-20-000019

Insider Transaction Report

Form 4
Period: 2020-01-10
Kaba Samer
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2020-01-10+17,50017,500 total
    Exercise: $6.75Exp: 2030-01-09Common Stock (17,500 underlying)
Footnotes (1)
  • [F1]Becomes exercisable in equal monthly installments over 48 months beginning one month after the vesting commencement date of January 10, 2020, provided the Reporting Person has provided continuous service to the Issuer through the applicable vesting date.

Issuer

ALIMERA SCIENCES INC

CIK 0001267602

Entity typeother

Related Parties

1
  • filerCIK 0001773634

Filing Metadata

Form type
4
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 4:32 PM ET
Size
5.3 KB